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Background: Malaria is a vector borne-parasitic disease transmitted through the bite of the infective female
Anopheles mosquitoes. Five Plasmodium species have been recognized by World Health Organization (WHO) as the
causative agents of human malaria. Generally, microscopic examination is the gold standard for routine malaria
diagnosis. However, molecular PCR assays in many cases have shown improvement on the sensitivity and specificity
over microscopic or other immunochromatographic assays.
Methods: The present study attempts to screen 207 suspected malaria samples from patients seeking treatment in
clinics around Sabah state, Malaysia, using two panels of multiplex PCRs, conventional PCR system (PlasmoNex™)
and real-time PCR based on hydrolysis probe technology. Discordance results between two PCR assays were further
confirmed by sequencing using 18S ssu rRNA species-specific primers.
Results: Of the 207 malaria samples, Plasmodium knowlesi (73.4% vs 72.0%) was the most prevalent species based
on two PCR assays, followed by Plasmodium falciparum (15.9% vs 17.9%), and Plasmodium vivax (9.7% vs 7.7%),
respectively. Neither Plasmodium malariae nor Plasmodium ovale was detected in this study. Nine discrepant species
identification based on both the PCR assays were further confirmed through DNA sequencing. Species-specific
real-time PCR only accurately diagnosed 198 of 207 (95.7%) malaria samples up to species level in contrast to
PlasmoNex™ assay which had 100% sensitivity and specificity based on sequencing results.
Conclusions: Multiplex PCR accelerate the speed in the diagnosis of malaria. The PlasmoNex™ PCR assay seems to
be more accurate than real-time PCR in the speciation of all five human malaria parasites. The present study also
showed a significant increase of the potential fatal P. knowlesi infection in Sabah state as revealed by molecular
PCR assays.
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Malaria is a mosquito-borne parasitic disease cause by
the unicellular, eukaryotic protozoan parasites of the
genus Plasmodium and the infective female Anopheles
mosquitoes are the sole vector of human-to-human trans-
mission. Malaria continues to be one of the most severe
global public health problems that affect many of the* Correspondence: khchua@um.edu.my
†Equal contributors
5Department of Biomedical Science, Faculty of Medicine, University of
Malaya, 50603 Kuala Lumpur, Malaysia
Full list of author information is available at the end of the article
© 2015 Lee et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.tropical and subtropical poorest nations. Five causa-
tive Plasmodium parasites have been recognized by
World Health Organization (WHO) as able to infect
humans [1].
Malaysia is situated in the hot, humid equatorial region
and, therefore, is receptive and vulnerable to the trans-
mission of malaria. The malaria main focal regions in
Malaysia include Sabah and Sarawak states situated on the
Borneo Island and central interior regions of Peninsular
Malaysia. These areas are also the home for a majority of
the isolated indigenous populations. Despite significant
reduction in malaria cases over the centuries, the surge ofis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Borneo, poses a challenge to malaria control programmes,
which aim to eliminate malaria in Peninsular Malaysia by
2015 and in Malaysian Borneo by 2020 [1,2].
The empirical clinical diagnosis remains the most
common method to diagnose malaria that is based on
the observation of the clinical features of the disease.
However, the accuracy of this clinical presumptive diag-
nosis is poor due to extremely wide spectrum of clinical
signs and symptoms ranging from mild to severe mal-
aria. Basically, microscopy (parasite morphology identifi-
cation), immunochromatographic-based rapid diagnostic
test (antigen detection), and molecular PCR assays
(parasite nucleic acid detection) are the three main mal-
aria diagnostic methods and they target the parasites in
the peripheral blood with wide ranges of sensitivity and
specificity as reviewed by Moody [3].
Overall, the advent of molecular PCR-based diagnos-
tics has produced higher specificity and sensitivity in the
identification and differentiation of all five human malaria
parasites up to species levels. As a whole, the currently
described molecular nucleic acid amplification PCR assays
can be subdivided into three categories, there are: i)
conventional-based PCR assays, such as nested PCR [4-6],
semi-nested PCR [7], and single step multiplex PCR [8,9],
ii) real-time or quantitative PCR (qPCR) assays based on
fluorescence dyes (SYBR Green, high resolution melting)
or hydrolysis probes technologies [10-12], and iii) the
simplest and least technically demanding loop-mediated
isothermal amplification (LAMP) assay [13]. Overall, PCR
is able to detect parasites at low titer, generally below 5
parasites/μl of blood for all five human Plasmodium para-
sites [3,7-9,11]. Amongst these molecular assays, nested
PCR [4-6] targeting 18S ssu rRNA genes of all five human
malaria parasites has been considered the molecular gold
standard for malaria detection. However, due to the cum-
bersome and multiple amplification reactions that are
needed in nested PCR assay (at least six PCRs conducted
to differentiate all five human Plasmodium species), many
researchers have attempted to develop a simpler, single
step multiplex PCR system, which allows simultaneous
identification of malaria parasites in a single tube reaction
[8-12]. Multiplex PCR undoubtedly shorten the time and
may be a useful diagnostic adjunct for diseases, such as
malaria, that require prompt and effective treatment.
In the present study, 207 patient samples suspected
for malaria were screened using two multiplex PCR
assays both targeting 18S ssu rRNA gene of human
Plasmodium species, single-step multiplex PCR assay
(PlasmoNex™) [9] and combinations of two real-time
PCR assays based on hydrolysis probes technique
[10,12,14], respectively. Due to the lack of P. ovale case in
Malaysian scenario, real-time primers and probe specific
for this species was precluded in the present study. Theresults obtained from two PCR assays (PlasmoNex™ PCR
and real-time PCR) were then compared. The discor-
dances at the species level of two PCR assays were then
confirmed by DNA sequencing. Overall, the aim of the
present study was to test the application of these two pub-
lished multiplex PCR platforms in the clinical diagnosis of
malaria disease.
Methods
Study site and sample collection
The 207 clinical suspected malaria blood samples for the
present study were collected between June 2012 and
January 2013 from patients seeking medical care at gov-
ernment clinics around Sabah state, Malaysia. Approxi-
mately 3 ml of whole blood were collected in EDTA
tube. Standard Giemsa-stained thick and thin blood
films were prepared in the field and Plasmodium infec-
tion was determined by a field microscopist and then
sent together with blood tubes to Sabah State Health
Department. Genomic DNA was extracted from 200 μl
of blood sample using QIAamp DNA Mini Kit (Qiagen,
Germany), accordingly to manufacturer’s instructions.
Hexaplex PCR (PlasmoNex™)
Multiplex PCR was carried out as described by Chew
et al. [9]. Generally, 15 μl of PCR reagent mixture contain-
ing 20 mM of Tris–HCl, 20 mM of KCl, 5 mM of (NH4)
2SO4, 3.0 mM of MgCl2, 0.2 μM of each dNTP, pooled
primers mixture, 1 U of Maxima® Hot Start Taq DNA
polymerase (Thermo Scientific, USA), and 1.5 μl (~10 ng)
of template DNA were used in the detection study. PCR
amplification was carried out with an initial denaturation
step at 95°C for 5 min; 35 repeated cycles at 95°C for
30 sec, 56°C for 30 sec, 65°C for 40 sec, followed by a final
extension at 65°C for 10 min using Mastercycler® Gradient
5331 (Eppendorf, Hamburg, Germany). The amplified
products were visualized on ethidium bromide stained 3%
(w/v) agarose gel (Promega, Madison, WI) and gel image
was captured using Gel Doc™ 2000 Gel Documentation
System (Bio-Rad, USA).
Real-time PCR
Real-time PCR was performed by using primers, probes,
and reaction conditions described previously by Shokoples
et al. [12] and Divis et al. [14] with the following modi-
fications: fluorophores for probes of P. falciparum were
changed to Cy5-BHQ-1 and P. vivax to Texas Red-BHQ-2.
Primers and probes were synthesized by Bioneer Cor-
poration (South Korea) and are listed in Table 1 with the
respective concentrations for each reaction. Three separ-
ate reactions were performed: (1) a screening reaction for
the presence of Plasmodium species with Plasmodium
genus-conserved primers pair (Plasmo1 and Plasmo2)
and the Plasprobe to detect a conserved region of the
Table 1 Primers and probes used for screening and identification of Plasmodium species
Species Primer or probe Conc. [nM] Sequence (5’→ 3’)b References
Plasmodium spp. Plasmo1 200 GTTAAGGGAGTGAAGACGATCAGA [10]
Plasmodium spp. Plasmo2 200 AACCCAAAGACTTTGATTTCTCATAA
Plasmodium spp. Plasprobe 50 FAM-ACCGTCGTAATCTTAACCATAAA
CTATGCCGACTAG-BHQ-1
P. falciparum Fal-F primer 200 CCGACTAGGTGTTGGATGAAAGTGTTAA [10,12]
P. falciparum Falcprobea 80 Cy5-AGCAATCTAAAAGTCACCTCGAA
AGATGACT-BHQ-1
P. vivax Viv-F primer 50 CCGACTAGGCTTTGGATGAAAGATTTTA
P. vivax Vivprobea 80 TR-AGCAATCTAAGAATAAACTCCGA
AGAGAAAATTCT-BHQ-2
P. malariae Mal-F primer 50 CCGACTAGGTGTTGGATGATAGAGTAAA
P. malariae Malaprobe 50 FAM-CTATCTAAAAGAAACACTCAT-MGBNFQ
P. knowlesi Pkprobe 80 FAM-CTCTCCGGAGATTAGAACTCTTA [14]
GATTGCT-BHQ-1
Human β2M-F 900 TGAGTATGCCTGCCGTGTGA [15]
Human β2M-R 900 ACTCATACACAACTTTCAGCAGCTTAC
Human β2M-probe 100 FAM-CCATGTGACTTTGTCACAGCCCA
AGATAGTT-TAMRA
aProbe sequence is as previously published [11], with modified fluorophores.
bTAMRA, 6-carboxytetramethylrhodamine; MGBNFQ, minor groove binding nonfluorescent quencher; BHQ, black hole quencher; Cy5, cyanine; FAM, carboxyfluorescein;
TR, Texas Red.
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aria parasites [10], (2) a multiplex PCR for the detection
of three Plasmodium species, i.e., P. falciparum, P. vivax,
and P. Malariae, using species-specific forward primers
paired with Plasmo2, and species-specific probes [12], and
(3) a monoplex PCR for the detection of P. knowlesi with
Plasmo1, Plasmo2 primers and a Pk probe [14]. Briefly,
the monoplex and multiplex assays for Plasmodium
speciation were performed with a final volume of 25 μL
containing 5 μL of template DNA, 12.5 μL QuantiFast
Multiplex PCR master mix (Qiagen, Germany), and 7.5 μL
of pooled primers and probes mix. All assays were per-
formed under standard conditions (1 cycle of 95°C for 5
mins; 45 repeated cycles of 95°C for 30 sec and 60°C for
30 sec) with the CFX96 Real-time PCR machine (Bio-Rad,
USA). A cut-off of 40 cycles was used to define positive
samples. The test panel included a number of controls:
negative sample extraction as a negative control, β2-
macroglobulin (β2M) target amplification as a positive
extraction control for the sample and a positive refer-
ence control to detect any variation between runs and
non-template control for each of the master mixes.
Sequencing
Sequencing was only performed on the samples for
which PlasmoNex™ and real-time PCR gave different
speciation results. Sequencing was carried out with ABIPrism BigDye terminator cycle sequencing kits and ABI
Prism 310 automated sequencer (Applied Biosystems,
USA). Sequencing results were then BLAST searched on
GenBank database for species determination.
Diagnostic sensitivity and specificity for three species
The diagnostic sensitivity (true positive rate), specificity
(true negative rate), positive predictive value (PPV)
(probability that the diseases is present when the test is
positive), negative predictive value (NPV) (probability
that the diseases is not present when the test is negative),
and disease prevalence (DP) of three species, i.e., P. vivax,
P. falciparum, and P. knowlesi were calculated, based on
207 malaria positive samples, using PlasmoNex™ as the
standard. The 95% confidence interval (95% CI) was also
calculated using MedCalc-Diagnostic test evaluation [16].




Of the 207 samples analyzed, 20 (9.7%), 33 (15.9%), and
152 (73.4%) samples were identified as single infection of
P. vivax, P. falciparum, and P. knowlesi respectively,
whereas two (1.0%) samples were examined as triple-
species mixed infections of P. vivax, P. falciparum, and P.
knowlesi, which were further confirmed via sequencing.
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the samples (Table 2).
Real-time PCR
Real-time PCR results indicated that all 207 malaria
samples were positive with Plasmodium infections based
on genus-conserved primers and probe, i.e., Plasmo1,
Plasmo2, and Plasprobe. Species-specific real-time PCR
indicated that 202 malaria samples were caused by
single-species infection, i.e., 16 (7.7%), 37 (17.9%), 149
(72.0%) by P. vivax, P. falciparum, and P. knowlesi, re-
spectively, while determination up to species level based
on species-specific primers and probes failed for the bal-
ance five samples. No P. malariae infection was detected
based on real-time PCR assay (Table 2).
Sequencing result
Nine discordant results between two PCR assays were
further confirmed via sequencing using 18S ssu rRNA
species-specific primers. Four and one samples that
failed in speciation based on species-specific real-time
PCR primers and hydrolysis probes were actually single
infected sample of P. vivax and P. knowlesi, respectively.
Two samples diagnosed as P. falciparum infection based
on multiplex real-time PCR assay were actually infected
with P. knowlesi based on sequencing results and BLAST
data, which were in agreement with the results obtained
from PlasmoNex™ assay. Another two Falcprobe positive
samples, which were suspected with mixed infections
based on PlasmoNex™ results were then sent for sequen-
cing and further confirmed that both samples were actu-
ally triple-species mixed infections with P. falciparum, P.
vivax, and P. knowlesi. All mentioned sequencing results
(n = 9) were in agreement with the results obtained from
PlasmoNex™.
Diagnostic sensitivity and specificity for three species
The sensitivity and specificity of the real-time PCR in
detecting P. vivax, P. knowlesi and P. falciparum were
72.7% and 100%, 96.8% and 100%, and 100% and 98.8%,
respectively in species diagnosis. For P. falciparum posi-
tive samples, the probability of detection using the real-Table 2 Comparison of diagnosis of Plasmodium species by P
the sample collected from Sabah (n = 207)
Plasmodium spp No. of cases identi
P. vivax P. falcipa
No. of cases identified by
species-specific real-time PCR* (%)
P. vivax 16 (7.7) 0
P. falciparum 0 33 (15.9)
P. knowlesi 0 0
No speciation 4 (1.9) 0
Total 20 (9.7) 33 (15.9)
*Real-time PCR speciation results were based on species-specific hydrolysis probes.time PCR was 94.6% but the probability to not detect
the P. vivax and P. knowlesi was 96.9% and 91.4%,
respectively, in those negative samples when compared
to PlasmoNex™. This indicated that P. knowlesi (74.4%)
was the most prevalent among all Plasmodium species,
followed by P. falciparum (16.9%) and P. vivax (10.6%)
in Sabah (Table 3).
Discussion
PlasmoNex™ is a conventional multiplex PCR system
developed for the simultaneous identification and differ-
entiation of all five human malaria parasites in a single
tube reaction together with an internal control. The sys-
tem showed to be of high accuracy (sensitivity and specifi-
city) in identification and differentiation of all five human
Plasmodium species in both single- and mixed-species in-
fections [9] and is applicable for usage in epidemiological
study [17]. The real-time PCR applied in the present study
was adapted from three published studies [10,12,14]. The
genus-conserved primers, i.e., Plasmo1 and Plasmo2 and
Plasprobe used to detect the presence of Plasmodium spe-
cies originated from Rougemont et al. [10]. In their study,
four major human Plasmodium species-specific probes,
i.e., Falcprobe, Vivprobe, Ovaprobe, and Malaprobe were
developed in order to further discriminate malaria para-
sites up to species level [10]. Basically, species-specific
real-time PCR described by Rougemont et al. was de-
signed to simultaneously identify all four species in two
separate multiplex PCR mixtures, i.e., Falcprobe multi-
plexed with Vivprobe and Malaprobe multiplexed with
Ovaprobe. The Pk probe specific for P. knowlesi de-
tection was then developed in complementary to this
Plasmodium screening assay [14]. One of the limitation
of Rougemont et al. method is the inability of the assay
to detect mixed infections, which is likely due to compe-
tition of the conserved primers (Plasmo1 and Plasmo2)
for the different templates and biasness in amplification of
species with higher level of infection [12,18]. Several years
later, Shokoples et al. improved this method by using a set
of specific-specific forward primers targeting four major
Plasmodium species (excluding P. knowlesi) in replace-
ment of genus-conserved forward primer (Plasmo1). InlasmoNex™ PCR and hydrolysis probes real-time PCR for
fied by PlasmoNex™ (%)
rum P. knowlesi P. vivax + P. knowlesi + P. falciparum Total
0 0 16 (7.7)
2 (1.0) 2 (1.0) 37 (17.9)
149 (72.0) 0 149 (72.0)
1 (0.5) 0 5 (2.4)
152 (73.4) 2 (1.0) 207 (100.0)
Table 3 The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and disease
prevalence (DP) of the real-time PCR compared to PlasmoNexTM PCR
PlasmoNex™ as standard (Confirmed by sequencing)
Species P. vivax P. falciparum P. knowlesi
Test* Positive Negative Positive Positive Negative Positive
Species-specific real-time PCR Positive 16 0 35 2 149 0
Negative 6 185 0 170 5 53
Percentage 95% CI Percentage 95% CI Percentage 95% CI
Sensitivity 72.73 49.78 to 89.20 100.00 89.90 to 100.00 96.75 92.58 to 98.93
Specificity 100.00 98.01 to 100.00 98.84 95.85 to 99.83 100.00 93.21 to 100.00
PPV 100.00 79.24 to 100.00 94.59 81.77 to 99.18 100.00 97.53 to 100.00
NPV 96.86 93.28 to 98.83 100.00 97.83 to 100.00 91.38 81.01 to 97.11
DP 10.63 6.78 to 15.65 16.91 12.07 to 22.72 74.40 67.88 to 80.19
*Included two triple-species mixed infections and five none speciation samples.
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and species-specific probes, this real-time PCR assay was
optimized for the multiplex assay in a single tube reaction,
which also included the careful validation of single- and
mixed-species infections [12]. Generally, there are several
advantages of real-time PCR over conventional PCR. The
real-time PCR is considered a rapid assay and the result is
obtained in a straightforward manner based on comple-
tion of amplification without any post-PCR downstream
analysis such as gel electrophoresis for result interpret-
ation. The ability in quantification of DNA copy number
as correlated with parasites density by microscopic exam-
ination which cannot be achieved by conventional PCR
approaches is the major strength of the real-time PCR
assays; however, the cost of reagents and equipment are
much higher than that of any conventional PCR assays.
Quantitative analysis of parasitaemia by real-time PCR
does correspond with the clinical presentation of the dis-
ease and is useful in post-treatment detection of Plasmo-
dium DNA to monitor response to therapy and/or to
predict treatment failure possibly due to parasite resist-
ance [19].
In the present study, no diagnostic divergence was
assumed in the experiment design as the DNA samples
were from the same source and both PCR assays de-
scribed here were targeting Plasmodium 18S ssu rRNA
gene. All DNA samples used here were successful extracted
as indicated by the presence of internal positive control
band (i.e., human β-haemoglobin in PlasmoNex™ assay)
and fluorescence signal (i.e., human β2-macroglobulin in
real-time PCR).
The PlasmoNex™ PCR assay is the only multiplex system
that allows simultaneous identification and differentiation
of all five human Plasmodium parasites in a single tube re-
action. The accuracy of the assay was also being observed
in the present study, in which two triple-species mixed in-
fections were successful diagnosed and further confirmed
by sequencing data. Of the 207 infected samples, nine haddiscrepant species identification based on two PCR assays.
Two samples with P. falciparum positive as determined by
real-time PCR were actually P. knowlesi single-species
infection determined by PlasmoNex™ and confirmed by
DNA sequencing. Five Plasmodium positive (Plasprobe
positive) samples, which failed to be determined up to spe-
cies level (species-specific probes negative) by real-time
PCR were actually single infection of P. vivax (n = 4) and
P. knowlesi (n = 1) based on PlasmoNex™ assay and se-
quencing results. The major finding in the present study
was that the species-specific real-time PCR did not seem
to be as specific as PlasmoNex™ assay especially in the
detection of mixed infections. In two samples with triple-
species infections by P. vivax, P. falciparum, and P. know-
lesi, multiplex real-time PCR (for P. vivax, P. falciparum,
and P. malariae) and monoplex real-time PCR (for P.
knowlesi) only successful picked up the P. falciparum
infection. Failure of the multiplex real-time PCR indicated
that there were possibly some internal diagnosis con-
straints, maybe due to competition for genus-conserved
reverse primer or PCR reagents. Inter-laboratory variation
such as difference in PCR reagent used, source of hydroly-
sis probes, type of thermocycler used, etc. might also be
the contributing factors (not tested here). The failure of
monoplex real-time PCR in the determination of P. know-
lesi in cases with mixed infections can be explained by the
possibility of diagnostic constraint present in the real-time
PCR as commented on the real-time PCR developed by
Rougemont et al. [12,18]. The Plasmo1 and Plasmo2
adopted in monoplex real-time PCR for P. knowlesi de-
tection are genus-conserved primers for all five human
Plasmodium species, therefore in the cases of mixed
infections, P. falciparum and P. vivax fragments may
also be co-amplified with the P. knowlesi fragment and
this certainly lowered the concentration of P. knowlesi
amplicon, possibly to the level below the threshold of
Pk probe. Furthermore, in the mixed infections, parasite
densities are varied substantially and there is a possibility
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loads. In contrast, this diagnostic constraint (primer com-
petition) was not observed in PlasmoNex™ assay, because
the sensitivity and specificity of the hexaplex PCR assay
were tested empirically to all five human Plasmodium
species. From the results, the sensitivity and specificity of
multiplex real-time PCR utilized in the present study seem
to be limited especially in the cases of mixed infections.
Furthermore, this real-time PCR assay was optimized and
tested on four human Plasmodium species excluding P.
knowlesi. Further validation on the sensitivity and specifi-
city of the assay are needed prior to recruiting this assay
as a routine malaria diagnostic tool.
In Malaysia, P. knowlesi is recognized as a common
cause of severe and potentially fatal human malaria. To
date, 19 knowlesi malaria deaths have been reported in
Malaysia Borneo, 12 cases in Sabah state [20,21] and seven
cases in Sarawak [22-24], confirmed by PCR. Again, 72%
of the malaria cases caused by P. knowlesi were confirmed
using both molecular approaches in this study (Table 2).
This further emphasizes the necessity to include mole-
cular specific assay for P. knowlesi diagnosis as well as in
surveillance and epidemiological studies.
Conclusions
Malaria is predominantly widespread in the tropical and
subtropical regions and exerts immense health and eco-
nomic burdens in many economic disadvantaged coun-
tries. Microscopic examination is the global accepted
gold standard for routine laboratory diagnostic method
for malaria. The invention of molecular PCR diagnostic
tools can be useful for prospective and retrospective
analysis of samples for surveillance and epidemiological
studies. Of the currently available PCR assays, a straight-
forward single step multiplex PCR speed up the time for
results compared with conventional molecular gold
standard nested PCR assay. The PlasmoNex™ PCR assay
seems to be more accurate than species-specific real-
time PCR in the identification and differentiation of all
five human malaria parasites up to species level in single-
as well as mixed-species infections. This assay has suc-
cessfully detected two triple-species mixed infections,
which were misdiagnosed as P. falciparum single-species
infection by real-time PCR. This suggests that Plasmo-
Nex™ PCR assay may serve as an ideal adjunct method for
accurate and effective diagnosis of patients presenting
with malaria symptoms. The present study again provide
evidences that P. knowlesi infections appear to be on the
increasing trend, with the species now accounting for the
majority of malaria cases in Sabah state after the state
successful controlled malaria caused by P. falciparum and
P. vivax. The increasing number of P. knowlesi infection
that can be potentially lethal is now not only widespread
in Malaysia but there is also a trend of emergence in manyother countries of Southeast Asia. The growing impact of
ecotourism and economic development in Malaysia are
expected to subsequently lead to further increase in cases
among locals and among travellers. Clinicians and labo-
ratory personnel should be alert of this emerging species
because it can be confused with benign P. malariae when
diagnosed solely by microscopy.
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